Document Detail

Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL): analysis of overdose cases reported to the Swiss Toxicological Information Centre.
MedLine Citation:
PMID:  15517507     Owner:  NLM     Status:  MEDLINE    
We analysed 141 cases of Gamma-hydroxybutyric acid (GHB) and Gamma-butyrolactone (GBL) intoxication reported by physicians to the Swiss Toxicological Information Centre between 1995 and 2003. GHB and GBL intoxication are associated with considerable morbidity. Multiple drug use is common. Overdosing frequently results in non-reactive coma, which accounts for the severity of the intoxication and the costs occasioned by management.
Matthias E Liechti; Hugo Kupferschmidt
Related Documents :
11785597 - Ciguatera poisoning: a global issue with common management problems.
6501847 - A case of fatal strychnine poisoning.
441767 - Myopathy of chronic organophosphate poisoning: a clinical entity?
24011977 - Circumscribed palmar or plantar hypokeratosis 10 years after the first description: wha...
7785717 - Using the case method to develop clinical reasoning skills in problem-based learning.
21061807 - Hysteroscopic diagnosis of a high-grade endometrial sarcoma in a 41-year-old woman.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Swiss medical weekly     Volume:  134     ISSN:  1424-7860     ISO Abbreviation:  Swiss Med Wkly     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2004-11-01     Completed Date:  2004-12-30     Revised Date:  2011-02-15    
Medline Journal Info:
Nlm Unique ID:  100970884     Medline TA:  Swiss Med Wkly     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  534-7     Citation Subset:  IM    
Department of Internal Medicine, University Hospital, Zurich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
4-Butyrolactone / poisoning*
Overdose* / epidemiology,  physiopathology
Sodium Oxybate / poisoning*
Switzerland / epidemiology
Reg. No./Substance:
502-85-2/Sodium Oxybate; 96-48-0/4-Butyrolactone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevalence of underweight, overweight and obesity in Turkish adolescents.
Next Document:  Cardiovascular drug class specificity: beta-blockers.